News
-
Opioid prescriber fail
Tuesday | Mar 6 2018THE NSW Health Care Complaints Commission (HCCC) has brought Dr Arthur Macaro Echano before the NSW Civil and Administrative Tribunal and he was found guilty of prescribing S4D and S8 drugs for 12 patients with a history of drug abuse - Echano's registration was cancelled and he is to pay costs.
-
TWC raises $1.2m for ovarian cancer
Tuesday | Mar 6 2018TERRYWHITE Chemmart's total fundraising support for Ovarian Cancer Australia (OCA) is expected to hit $1,225,550 in this, their 12th year of association, following a month of fundraising activities throughout Feb.
-
BD Dose Innovations deal
Tuesday | Mar 6 2018BECTON, Dickinson and Company (BD) has announced the acquisition of the sales and support operations for Rowa Technologies in Australia and New Zealand.
-
PSA honours pharmacy leaders
Tuesday | Mar 6 2018THE Pharmaceutical Society of Australia (PSA) South Australia and Northern Territory branches honoured four leading pharmacists at a ceremony in Adelaide last month, with Dr Janet Sluggett named as the Pharmacist of the Year.
-
Bid to ramp up vax rate
Tuesday | Mar 6 2018THE Federal Government has commenced a new campaign to target parents with the message that they need to vaccinate their children.
-
Weekly Comment
Monday | Mar 5 2018
05 Mar 18
King cat amongst the pharmacy pigeonsWELCOME to PD's weekly comment feature.
-
Dispensary Corner
Monday | Mar 5 2018
05 Mar 18THE source of much workplace consternation over the years, the humble "smoko" break has been known to leave many non-smokers feeling jealous and angry over all the lost productivity by their smoke-sodden associates.
-
Daclizumab review
Monday | Mar 5 2018THE European Medicines Agency says it is urgently reviewing multiple sclerosis medicine Zinbryta (daclizumab) after seven cases of serious inflammatory brain disorders in Germany and Spain.
-
Fish oil in pregnancy
Monday | Mar 5 2018TAKING a daily fish oil capsule during pregnancy and the first few months of breastfeeding may reduce a baby's risk of food allergy, according to a new research analysis out of Imperial College London.
-
Nanabis training
Monday | Mar 5 2018ASX-LISTED Medlab is expecting a total of around 500 attendees at a series of medical education seminars in Sydney, Melbourne and Brisbane this month, which it says are in keeping with the requirements of the TGA's Special Access Scheme for its Nanabis nanotechnology buccal absorption cannabis product.
